The transcriptional basis of sebocyte differentiation and lipid production is mostly unclear.
INTRODUCTION
Investigating the function of the sebaceous gland (SG) under normal and pathological conditions is a major research interest in dermatology. This includes investigations into the transcriptional mechanisms that regulate lipid metabolism and inflammatory responses of sebocytes (Toth, et al., 2011) . Identification of specific regulatory mechanisms and key actors in these processes is essential to fully understand the normal physiological function and to clarify the pathophysiological involvement of SGs. A particularly relevant area of research is the regulation of gene expression by transcription factors responding to changes in fatty molecules and therefore linking metabolic processes to gene regulation.
Peroxisome proliferator-activated receptors (PPARs) are lipid activated nuclear receptors, playing roles in sebaceous lipogenesis, and differentiation (Alestas, et al., 2006; Trivedi, et al., 2006) . In particular, the lipid activated nuclear receptor, peroxisome proliferator-activated receptor gamma (PPARγ) plays key roles in adipocyte, liver, macrophage and dendritic cell differentiation as well as in lipid metabolism (Forman et al., 1995; Tontonoz et al., 1998; Kim et al., 2001 Ferre, 2004 Knouff and Auwerx, 2004; Szatmari et al., 2004, Nagy et al; 2012) . In addition, PPARγ is expressed in SGs (Deplewski and Rosenfield, 2000; Kim et al., 2001; Zouboulis et al., 2005; Alestas et al., 2006; Trivedi, et al., 2006; Michalik and Wahli, 2007) . Furthermore, PPARγ may be an important molecule in acne vulgaris, the most frequent SG-related dermatosis with abnormal lipid storage and inflammation (Anttila et al., 1992; Zouboulis, 2003; Zouboulis et al., 2005; Alestas et al., 2006; Trivedi et al., 2006) . Arachidonic acid (AA) markedly enhances lipid synthesis in SZ95 sebocytes (Wrobel et al., 2003; Alestas et al., 2006; Tóth et al., 2009; Géczy et al., 2012) and some of this induction might be regulated via PPARγ (Alestas et al., 2006) . Furthermore, AA is metabolized via various pathways to a large variety of derivates (Harizi et al., 2008) , and selected metabolites act as potent endogenous ligands of PPARs, especially of PPARγ in fibroblasts and adipocytes (Forman et al., 1995; Kliewer et al., 1997) . However, the nature and identity of endogenous ligands that activate PPARγ in the skin are not known.
Potential ligands of PPARs include fatty acids, various eicosanoids, and other lipids found in the skin and also in SGs. (Trivedi, et al., 2006) . Previous studies have shown that AA can activate PPARγ; however, it is highly likely that not AA, but some of its metabolites are bioactive mediators of PPARγ activation ( Alestas et al. 2006; Thuillier et al., 2002; Kliewer et al., 1995) . These findings prompted us to systematically assess the role of PPARγ in human sebocytes. We also sought to identify endogenous PPARγ ligands among AA derivatives, which activate the receptor, along with gathering evidence on target gene expression and roles in differentiation and lipid metabolism both in situ in normal and pathological SGs and in vitro in a model cell line.
To address these issues, including the expression levels of PPARs and the presence of PPARγ in normal and pathological conditions, we have examined the expression of this transcription factor in sebocytes in two different human SG model systems: i) in laser-micro-dissected SG from fresh frozen tissues; and ii) in a human immortalized SG cell line, namely SZ95. We also determined PPARγ expression pattern in sebaceous hyperplasia, adenoma and carcinoma tissues. We found that AA and AA-derived keto-metabolites apparently modulate PPARγ activity, which appears to be important in the regulation of SG differentiation and lipid biosynthesis.
RESULTS

PPARγ and its target genes are expressed in normal human SGs in situ
First, we determined the expression level of PPARγ and markers of its activity in human SGs in situ. Immuno-labeling identified PPARγ protein expression predominantly in the nuclei of normal SGs of skin biopsies obtained from healthy volunteers (n=10) (Figure 1a ). In addition, SGs were isolated from donors of healthy (n=5) and pathologic (n=2) human skin tissues by laser-microdissection and mRNA levels of PPARγ were examined by quantitative real-time PCR (qPCR). The expression of PPARγ mRNA was higher in healthy SG than in pathologic (hyperplasia and adenoma) samples, although the latter was available only in limited numbers and therefore no definitive conclusions can be drawn (Suppl. Figure 1a) .
It is generally accepted that PPARγ activity is indicated by the mRNA expression of its target genes including the adipose differentiation related protein (ADRP) and PPARγ angioprotein related protein (PGAR), as established in other cell types (Forman et al., 1995; Szanto et al., 2004; Nagy and Szanto, 2005; Szatmari et al., 2006; Varga and Nagy, 2008) . We also found that laser-microdissected SG samples from healthy individuals express ADRP and PGAR mRNA at high levels (Suppl. Figure 1a) . These data suggest that PPARγ and also its target genes are present in human SGs.
PPARγ expression correlates with the differentiation stage of sebocytes
Next we sought to define the role of PPARγ in the process of sebocyte differentiation. Therefore, we investigated SGs from human biopsies obtained from patients with benign or malignant SG lesions. In order to document the differentiation stages of sebocytes within SG, we immunostained sections and measured mRNA for Ki67, a well known marker of active cell cycle, and for the androgen receptor (AR). Also, the grade of differentiation of sebocytes within the SG was classified. Immunostaining was scored semi-quantitatively according to previous reports (Cottle et al.,2013 , Tsujita-Kyutoku et al. 2003 (Figure 1b and Suppl. table 1.). In order to extend these analyses we used reference markers for basal immature sebocytes p63 protein (Tsujita-Kyutoku et al, 2003) . PPARγ was present at high levels in sebocytes of all samples (n=10) from patients with SG hyperplasia (Figure 1a ). Both the Ki67 and p63 markers stain nuclei of immature sebocytes located at the basal layers of normal SG, whereas AR was incorporating predominantly the basal and suprabasal cell layers, and to a lesser extent the central cells, as well. By contrast, PPARγ was detectable in terminally differentiated mature sebocytes located in the central regions of normal SGs, but was hardly detectable in basal layer cells. Double immunolabeling for Ki67 along with PPAR clearly demonstrated the predominantly different localizations for these two nuclear proteins discriminating the immature (Ki67 positive) cells from the mature (PPAR positive) ones, which appeared to be the rule for these marker expressions in normal and hyperplastic SGs.
We also analyzed samples of SG-tumours. When compared to normal and hyperplastic SGs, cells of sebaceous adenomas (n=10) generally expressed decreased amounts of PPAR, which appeared to decrease further in malignant tissues and sebaceous carcinomas (n=9) and down to hardly detectable levels in poorly differentiated neoplastic cells. In the same SG carcinoma samples, the un-affected normal tissue parts with intact sebaceous glands retained the significantly high PPARγ-specific nuclear protein expression levels (Suppl . Fig 1c) We then corroborated our results by investigating the PPARγ expression pattern and its signaling pathway during normal sebocyte differentiation. Therefore, terminally differentiated normal SG cells (i.e., from the central zone of the gland) and immature cells (from the basal-parabasal zones) were collected separately by in situ laser microdissection from fresh frozen human skin tissues; from the facial region of 5 different donors.
Subsequently, mRNA expressions of PPARγ, ADRP and PGAR, Ki67, AR were measured (Figure 1d ). PPARγ, ADRP and PGAR were expressed at low levels in basal cells, whereas higher expression was detected in the well-differentiated sebocytes of the central zone 4/5 samples (PPARγ), 3/5 samples (ADRP, PGAR). In contrast Ki67 and AR mRNA was expressed at high levels in the basal cell layer, and was expressed to a lesser degree or not detectable in central cells (AR 4/5 samples, Ki67,5/5 samples). These data together with findings from the 10 samples analyzed by immunohistochemisty indicated that PPARγ may be used as a potential marker of sebocyte differentiation.
Active PPARγ is present in human SZ95 sebocytes
To further explore how PPARγ functions in sebocytes we used a well-established human SG cell line, SZ95 sebocytes (Zouboulis et al., 1999) . Expressions of the three PPAR isoforms were detected at the mRNA level in SZ95 sebocytes (Suppl. Figure 1b) . Remarkably, PPARγ mRNA expression was highest among the PPAR isoforms. We measured the mRNA levels of RXR isoforms, which are the heterodimerization partners of PPARγ. Confirming a previous report (Tsukada et al., 2000) RXRα appeared to be the dominant RXR subtype in SZ95 sebocytes (Suppl. Figure 1b) .
Next, we investigated PPARγ activity in SZ95 sebocytes. We treated SZ95 sebocytes with the synthetic PPARγ agonist rosiglitazone (RSG) and measured the mRNA levels of two target genes, PGAR and ADRP. RSG (1-10 μM) induced significant upregulation of PGAR (ca. 32-fold) and ADRP (ca. 3-fold). The RXR agonist LG100268 (20-200 nM) also increased PGAR (ca. 46-fold) and ADRP (ca. 2-fold) expressions, respectively (Suppl. Figure   1b ). Administration of a PPARγ inhibitor, GW9662 markedly abrogated the RSG-induced target gene induction in a dose-dependent manner (1-10 μM). These data collectively suggest that PPARγ is active in human SZ95 sebocytes. This confirms our previous observations (Dobrosi et al., 2008) . Our findings also suggest that PPARγ and RXRα are likely to act on the same molecular pathways .
AA regulates sebocyte differentiation, in part via PPARγ-coupled signaling pathways
To further explore the biological consequences of PPARγ stimulation on SG biology, we also investigated the functional role of PPARγ in SZ95 sebocytes. Sebocyte differentiation is characterized by the synthesis of various lipids, among which neutral lipids represent the major part (Zouboulis et al., 1999; Rosenfield et al., 1998) . Confirming our previous results (Toth et al, 2009; Alestas et al., 2006) , first we showed that AA, one of the most effective differentiation inducer of SZ95 sebocytes, markedly enhanced lipid synthesis of the cells 
AA regulates the production of selected lipid molecules via PPARγ
To further explore how PPARγ activation affects lipid production in sebocytes, we treated the cells with AA (25 µM) and with a PPARγ antagonist GW9662 (10 µM) simultaneously for 24h and then analyzed the major neutral lipids and specific membrane lipids. We determined the relative abundance of major neutral lipid classes, such as TG, FFA, CE, CH, WE, and SQ using high performance thin layer chromatography (HPTLC) ( The other neutral lipids that were influenced by the addition of AA were CE and WE. AA elevated WE levels, however no effect of the PPARγ antagonist on this was observed.
Additionally, AA had no significant effect on the total CE levels regardless of the presence of the PPARγ antagonist (densitometric results not reported). Interestingly, basal CH level was significantly decreased by the PPARγ antagonist GW9662 as demonstrated by the quantitative analysis of CH by HPLC-MS (Figure 3b ). In contrast, concentration of SQ determined by HPLC-MS was not affected by AA alone or in combination with the PPARγ antagonist GW9662 (data not shown).
Next, using direct flow injection electrospray ionization tandem mass spectrometry (ESI-MS/MS), ten main specific membrane lipid groups were assessed: phosphatidylinositol, lysophosphatidylcholine, phosphatidylcholine, sphingomyelin, dihydrosphingomyelin, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, ceramide and glucosylceramide. AA had no significant effect on ceramides and glucosylceramides. Among the other 8 measured membrane lipid groups, AA induced significant alterations in the levels of 136 of the 198 measured lipid species (Figure 3d) . Importantly, the presence of the PPARγ inhibitor GW9662 significantly prevented the action of AA on 8 lipid species (Figure 3d ).
Among these molecules, AA decreased the level of seven types of phosphatidylinositol (PI) whereas it upregulated the expression of 18:2 lysophosphatidylcholine. These findings suggest that AA regulates the metabolism of these molecules in a PPARγ dependent fashion. Therefore, the AA-coupled PPARγ pathway may contribute to the generation of major neutral lipids and membrane phospholipid production. With this we comprehensively analyzed lipid changes upon AA treatment, and sorted out the ones requiring PPARγ activation.
The above data collectively suggest that i) PPARγ is indeed active in cultured SZ95 sebocytes where its activation resulted in a lipogenic action; ii) AA acts as a PPARγ agonist in SZ95 sebocytes; and iii) the effect of AA to enhance lipogenesis and hence sebaceous differentiation was only partially mediated by the activation of PPARγ and the related signaling (and hence other, PPARγ-independent signal transduction mechanisms are most likely involved) iiii) PGAR and ADRP can be regulated by other lipid mediators, and AA's effect is only partly PPARγ dependent. As an additional control we measured cell line viability with MTT, and none of the applied ligands induced cell death (Suppl. Figure 1b) .
AA metabolites activate PPARγ and induce lipogenesis in sebocytes
AA can be metabolized to a plethora of signal lipids (Harizi et al., 2008) . Therefore, we assessed whether certain AA metabolites can also induce similar cellular responses on human sebocytes. SZ95 sebocytes were treated with AA for 6 hrs and an HPLC-MS approach was then employed to quantitatively determine the levels of AA-derived signalling lipids. Among the several candidates, we primarily focused on eicosanoids which have a proven ability to activate PPARγ like 5-KETE, 12-KETE and 15-KETE.
Upon AA treatment, we detected increased concentrations of 5-KETE, 12-KETE, and 15-KETE (Figure 4a) . Furthermore, these endogenous AA metabolites administered at a concentration of 5 μM (Shiraki et al., 2005; O'Flaherty et al., 2005) significantly elevated sebaceous lipid synthesis (Figure 4b-c) , and in case of 5-KETE, 12-KETE, neutral lipid production was partially inhibited by PPARγ antagonist GW9662. To explore whether these molecules also activate PPARγ in another set of experiments, SZ95 sebocytes were treated similarly and expressions of PPARγ target genes were then assessed. We found that 5-KETE, 12-KETE and 15-KETE significantly increased the gene expression levels of PGAR and ADRP. However, the PPARγ antagonist GW9662 was able to inhibit the induction of PGAR only in the case of 12-KETE and 5-KETE (Figure 4d) , and the induction of ADRP in the case of 12-KETE (Figure 4e ). Taken together, these findings indicate that AA-metabolites play a role in sebaceous lipogenesis and that 12-KETE and 5-KETE are likely to signal via PPARγ.
DISCUSSION
The fact that PPARγ is expressed in normal SG, in primary sebocytes and in SZ95 sebocytes has been well documented (Smith and Thiboutot, 2008) . However, it was not know what might be the role of this transcription factor in situ. We intended to extend these studies by the combination of using laser microdissection and cellular models. We found that PPARγ appears to correlate with the more differentiated state of sebocytes. This was confirmed by using established markers of cell cycle activity and differentiation such as Ki67, p63 and AR molecules. Co-staining of Ki67 and PPARγ molecules gave indication of an inverse relationship. AR was expressed mostly in basal and parabasal cell layers, and showed an overlap with PPARγ expression in the parabasal layer. We also compared the expression of these molecules in pathologies. In sebaceous hyperplasia and found that the expressions of PPARγand the other markers were essentially the same as in normal SG. In contrast, the proportion of cells expressing PPARγ in sebaceous adenoma and sebaceous carcinoma is lower, but the proportion of Ki67, and p63 positive cells is higher (Figure 1a (Nakashiro et al., 2001 ) and also (estrogen/progesterone) receptor expression in breast cancers (Payne et al., 2008) . This suggests that PPARγ might be a reliable diagnostic marker of sebocyte differentiation state.
As far as the function of the receptor is concerned we had to rely on a model cell line. Using a model of AA-treated differentiated sebocytes (Alestas et al., 2006; Wrobel et al., 2003) , we observed that the lipid rich SZ95 sebocytes expressed high levels of PPARγ and also its target genes PGAR and ADRP (Suppl. Figure 1b) , consistent with our previous finding, where the AEA (endocannabinoid) induced differentiation/lipid production was shown to be induced via PPARγ (Dobrosi et al, 2008) . In addition, we provide pharmacological evidence indicating that the specific PPARγ antagonist GW9662 dose -dependently inhibited this AA mediated target gene induction (Suppl. Figure 1b) . Also, the RXR agonist LG100268 induced ADRP and PGAR mRNA elevation. Our interpretation of these data is that both PPARγ and RXR are active in human SZ95 sebocytes, and possibly are heterodimer partners, or act on the same molecular pathways (Suppl. Figure 1b) .
Prior research has shown that RSG-activated PPARγ has a role in sebaceous lipid production, a marker of sebocyte differentiation (Trivedi et al., 2006) . In our study both the natural ligand precursor, AA, and the synthetic ligand, RSG, induced sebaceous lipogenesis (Figure 2b) similar to previous results (Trivedi et al., 2006) . This suggests that PPARγ-induced gene activation coincides with sebocytes' neutral lipid production. We analyzed neutral lipids, which are the major components of the sebaceous lipid mixture, along with membrane lipid species (Figure 3b) . We found that, TG levels were significantly elevated by AA, and this effect was inhibited by PPARγ antagonist. It was previously shown, that PPARγ ligand RSG induced TG production (Trivedi et al, 2006) . These findings indicate that the elevation of TG by AA was the result at least partly of PPARγ activation, and AA takes part in TG formation as demonstrated by the elevation of AA-containing species among the total TG.
It is known that in sebocytes, RSG also induced cholesterol accumulation (Trivedi et al, 2006) . In our data, inhibition of PPARγ also lowered the basal level of CH. However AA did not have an effect on cholesterol level. It is likely that, under our experimental conditions, preformed AA caused remodelling of lipid species bearing FA side chains, such as GLP and TG, and affected minimally the non-esterified lipid components. Taken together these data suggest that TG and cholesterol production is likely to be regulated by PPARγ in sebocytes, It is also likely that pathways leading to neutral lipid formation were regulated by AA in a lipid species selective manner. AA treatment also causes PPARγ dependent elevation of some minor lipids, like LPC and PIs (Figure 3c ). In sebocytes, LPC is a minor phospholipid in membranes of lipid droplets consisting of monolayer phospholipids (Corsini et al., 2003) . Lipid droplets in a wide range of cell lines (i.e. adipocytes, keratinocytes) were shown to be involved both in deposition and storage of neutral lipids (Brasaemle et al, 1997; Heid et al., 1998) , and were shown to have ADRP protein on their surface. These data might indicate that PPAR is involved in the formation of these lipid droplets, i.e. neutral lipid storage or production. AA also significantly decreased the level of PIs in a PPARγ-dependent manner suggesting that enzymes, which are involved in the synthesis/degradation of PIs are also influenced by the receptor. The altered level of PIs, based on their versatile roles in various biological processes, might influence several functions of sebocytes, i.e. PIs are essential phospholipids in the formation of cellular membranes. Moreover, one group of their metabolic products, phosphoinositides, are key signal transduction molecules. The IP3 kinase pathway has a common part with the MAPK induced pathway, which was shown to be involved in AEA induced sebaceous lipid synthesis, in which PPARγ also plays a role (Dobrosi et al., 2008) .
Phopholipase A 2 (PLA2) isthe enzyme type responsible for hydrolyzing fatty acids like AA from glycerophospholipids (Scott, 1997) . Therefore they represent the source for the AA production. PLA2 was detected in various cells of skin and also in SZ95 sebocytes (Schagenet al. 2008) and treatment with active PLA2 increased neutral and polar lipid production of sebocytes (Schagenet al. 2008) . It seems possible, that PLA2 is one regulator of endogenous AA production in sebocytes, and it also determines the level of PPARγ activation in these cells at least in part. The identification of endogenous AA metabolites (such as 5-KETE, 12-KETE) by us supports this scenario. In addition, the reduction of the PIs level also suggests that there is a feedback mechanism aimed at the regulation of AA production if it is exogenously added.
Although PPARγ probably controls both the levels of major neutral lipids and levels of LPC and PIs, the exact mechanism of action in sebaceous differentiation remains to be discovered.
Another key goal of our study was to identify endogenous ligands. Various AA metabolites have been described as natural PPARγ ligands in the skin (Weindl et al., 2005) , adipocytes (Oster, et al. 2010) , cardiomyocytes (Hovsepian et al., 2010) and in several types of cancers (Maggiora, et al., 2010 ; Li et al., 2010; Dionne et al., 2010) . We found that the AA ketometabolites (5-KETE and 12-KETE) act as endogenous PPARγ ligands in SZ95 sebocytes as they elevated sebaceous lipid synthesis in a PPARγ-dependent manner (Figure 4b-e) .
In summary, our study provides evidence that PPARγ participates in the signaling mechanisms of sebocyte differentiation. We also demonstrated that AA-activated PPARγ is involved in the regulation of major neutral lipid and phospholipid biosynthesis. Finally, we presented that PPARγ is activated by AA keto-metabolites (5-KETE, 12-KETE). Taken together, our data implicate that AA activated PPARγ is an important regulator of differentiation and lipid metabolism in human sebocytes; therefore, PPARγ might be a potential therapeutic target molecule in sebaceous dermatoses.
MATERIALS AND METHODS
Detailed description of the employed techniques can be found in Supplementary data.
Cell culturing
Human immortalized sebocytes were cultured according to previously described protocol. (Zouboulis et al., 1999) .
Determination of intracellular lipids
For quantitative measurement of lipid content, SZ95 sebocytes (10,000 cells/well) were cultured in 96-well black-well/clear-bottom plates (Greiner Bio-One, Frickenhausen, Germany) in quadruplicates and were treated with compounds for 24 hrs. Then, cells were stained with 1 μg/ml Nile red (Sigma-Aldrich), and incubated at 37°C for 20 min. 
Determination of lipid species by ESI-MS/MS, HPTLC, and HPLC-MS
The composition of neutral lipids was investigated in SZ95 sebocytes based on the HPTLC and HPLC -MS with a time of flight MS detector (HPLC-ToF/MS) analyses of WE, TG, DG, CE, CH, FFA, and SQ (Fuchs et al. 2011 , Camera et al. 2010 . Quantitative determinations of AA, SQ and CH were performed with a triple quadrupole mass detector (QqQ) following HPLC separation (Camera et al., 2010) . The HPLC-MS systems were from Agilent Technologies (Waldbronn, Germany). For quantitative measurement of 9 membrane lipid classes in SZ95 sebocytes (PI, LPC, SPM, dhSPM, PE, PS, PG, CER, gluCER), direct flow injection electrospray ionization tandem mass spectrometry (ESI-MS/MS) in positive ion mode was applied, using the analytical setup and strategy described previously (Liebisch et al. 2002 , Liebisch et al. 2004 Liebisch et al. 2006) .
Detemination of eicosanods using HPLC-MS-MS methodology
For quantitative determination of eicosanoids and docosanoids in treated SZ95 cells, the HPLC-MS-MS methodology was used; the analytical sample preparation procedure is based on an established method used for retinoid quantification and was recently published for organs and serum analysis (Szklenar et al., 2013 in press) .
RNA isolation, Real Time -quantitative PCR (RT-qPCR)
Total RNA was isolated with Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to manufacture's protocol. Reverse transcription was performed at 42°C for 30 min,using Superscript II reverse transcriptase (Invitrogen). Quantitative PCR was performed on an ABI PRISM 7900 instrument (Applied Biosystems Foster City, CA, USA), 40 cycles of 95° C for 12s and 60°C for 1 min using TaqMan assays (Applied Biosystems). All PCR reactions were performed in triplicates with one control containing no RT enzyme. The comparative Ct method was used to quantify transcripts and normalize for human cyclophilin A. Mean and SD were calculated for both the normalized and the normalizer values for all experiments.
Data shown are mean±SD of three biological replicates measured in triplicates. * P< 0.05 was considered as significant change compared to vehicle treated control, or ligand treated cells.
Statistical analysis
When applicable, data were analyzed using a two tailed un-paired t-test ( 
Immunohistochemistry (IHC) and double immunofluorescence (IF)
IHC for PPAR was carried out using the biotin-free and tyramid-based CSAII kit (Dako, Glostrup, Denmark) according to the manufacturer's instruction and as described previously (Szanto et a.l, 2004; Szatmari et al., 2006; Gogolak et a.l, 2007) . Single IHC staining for androgen receptor (AR), and p63, and Ki67 were all detected with standard immuneperoxidase method using an EnVision + -HRP (horse-raddish-peroxidase) detection kit or an automated immune-stainer (Bond-Leica, UK) utilizing VIP (purple) or DAB (brown) chromogenic substrates for microscopic visualisation. The immunostained slides were then evaluated semi-quantitatively for distinct sebaceous glands/SG tumors reflecting the % of positive cells: -, negative; 1+, 0-20%; 2+, 20-50%; 3+, 50-75%; 4+, 75-100%.
Laser Capture Microdissection and RNA preparation
Serial cryosections were then made and mounted onto sterile membrane-containing microscopic slides (Jenkins et al., 2005) . Compartments of SGs were in situ lasermicrodissected (MMI-Olympus LCM system, Glattbrugg, Switzerland) and collected separately from the surrounding dermal tissue (Suppl. Fig. 1, c) .Then, Absolutely Nanoprep RNA isolation kit (Stratagene) was used according to the vendor's protocol. Samples were stored on -70ºC until use.
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